keyword
https://read.qxmd.com/read/38586822/bleeding-mass-in-remnant-stomach-unveiling-lynch-syndrome-18-years-after-bariatric-roux-en-y-gastric-bypass-surgery
#21
Adam Qazi, Karan Mathur, Ryan D Rosen, Alyssa Stroud, John Webber, Milton Mutchnick
There is sparse literature on the development of malignancy in remnant gastric stomach after bariatric Roux-en-Y gastric bypass surgery. We report a case of overt upper gastrointestinal bleeding from malignant adenocarcinoma in the remnant stomach presenting several years after bariatric Roux-En-Y gastric bypass surgery. The mass in the remnant stomach was surgically resected, and the patient was subsequently diagnosed with Lynch syndrome on genetic analysis.
April 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38584802/germline-mlh1-and-msh6-mutations-from-two-lynch-syndrome-families-identified-in-a-patient-with-early-onset-of-endometrial-cancer-a-case-report
#22
Yi-Ching Huang, Peng-Chan Lin, Pei-Ying Wu, Nai-Syuan Chen, Meng-Ru Shen, Yu-Min Yeh, Ya-Min Cheng
INTRODUCTION: Lynch syndrome is caused by a germline mutation in mismatch repair (MMR) genes, leading to the loss of expression of MMR heterodimers, either MLH1/PMS2 or MSH2/MSH6, or isolated loss of PMS2 or MSH6. Concurrent loss of both heterodimers is uncommon, and patients carrying pathogenic variants affecting different MMR genes are rare, leading to the lack of cancer screening recommendation for these patients.Case presentation:Here, we reported a female with a family history of Lynch syndrome with MLH1 c...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38583260/mitotic-abnormalities-precede-microsatellite-instability-in-lynch-syndrome-associated-colorectal-tumourigenesis
#23
JOURNAL ARTICLE
Marjaana Pussila, Aleksi Laiho, Petri Törönen, Pauliina Björkbacka, Sonja Nykänen, Kirsi Pylvänäinen, Liisa Holm, Jukka-Pekka Mecklin, Laura Renkonen-Sinisalo, Taru Lehtonen, Anna Lepistö, Jere Linden, Satu Mäki-Nevala, Päivi Peltomäki, Minna Nyström
BACKGROUND: Lynch syndrome (LS) is one of the most common hereditary cancer syndromes worldwide. Dominantly inherited mutation in one of four DNA mismatch repair genes combined with somatic events leads to mismatch repair deficiency and microsatellite instability (MSI) in tumours. Due to a high lifetime risk of cancer, regular surveillance plays a key role in cancer prevention; yet the observation of frequent interval cancers points to insufficient cancer prevention by colonoscopy-based methods alone...
April 6, 2024: EBioMedicine
https://read.qxmd.com/read/38575458/hereditary-cancer-syndrome-carriers-feeling-left-in-the-corner
#24
JOURNAL ARTICLE
Celia Diez de Los Rios de la Serna, Maria Teresa Lluch-Canut, Maria Paz Fernández-Ortega
OBJECTIVES: There is limited evidence on health promotion interventions in people with hereditary cancer syndromes or on their main sources of support and information. This study aimed to understand these patients' experiences and needs, including their information needs, their views on prevention and mental health, and the support they want from nurses. METHODS: This qualitative study included 22 people (8 previvors and 14 survivors) with hereditary breast and ovarian syndrome or Lynch syndrome from 10 European countries...
April 3, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38566849/testing-region-selection-and-prognostic-analysis-of-mlh1-promoter-methylation-in-colorectal-cancer-in-china
#25
JOURNAL ARTICLE
Xiaoli Tan, Yongzhen Fang, Xinjuan Fan, Weihao Deng, Jinglin Huang, Yacheng Cai, Jiaxin Zou, Zhiting Chen, Hanjie Lin, Liang Xu, Guannan Wang, Huanmiao Zhan, Shuhui Huang, Xinhui Fu
BACKGROUND: MLH1 promoter methylation analysis is recommended in screening for Lynch syndrome (LS) in patients with MLH1-deficient colorectal cancer (CRC). The study aims to identify specific methylation regions in the MLH1 promoter and to evaluate the clinicopathologic characteristics of and prognosis for patients with MLH1 methylation. METHODS: A total of 580 CRC cases were included. The DNA mismatch repair (MMR) protein expression was assessed by using immunohistochemistry (IHC)...
2024: Gastroenterology Report
https://read.qxmd.com/read/38562077/-erratum-to-utility-of-clinical-comprehensive-genomic-characterization-for-diagnostic-categorization-in-patients-presenting-with-hypocellular-bone-marrow-failure-syndromes
#26
JOURNAL ARTICLE
Piers Blombery, Lucy Fox, Georgina L Ryland, Ella R Thompson, Jennifer Lickiss, Michelle McBean, Satwica Yerneni, Alison Trainer, David Hughes, Anthea Greenway, Francoise Mechinaud, Erica M Wood, Graham J Lieschke, Jeff Szer, Pasquale Barbaro, John Roy, Joel Wight, Elly Lynch, Melissa Martyn, Clara Gaff, David Ritchie
No abstract text is available yet for this article.
April 1, 2024: Haematologica
https://read.qxmd.com/read/38558366/tumor-analysis-of-mmr-genes-in-lynch-like-syndrome-challenges-associated-with-results-interpretation
#27
JOURNAL ARTICLE
Paula Rofes, Núria Dueñas, Jesús Del Valle, Matilde Navarro, Judith Balmaña, Teresa Ramón Y Cajal, Noemí Tuset, Carmen Castillo, Sara González, Joan Brunet, Gabriel Capellá, Conxi Lázaro, Marta Pineda
BACKGROUND: Up to 70% of suspected Lynch syndrome patients harboring MMR deficient tumors lack identifiable germline pathogenic variants in MMR genes, being referred to as Lynch-like syndrome (LLS). Previous studies have reported biallelic somatic MMR inactivation in a variable range of LLS-associated tumors. Moreover, translating tumor testing results into patient management remains controversial. Our aim is to assess the challenges associated with the implementation of tumoral MMR gene testing in routine workflows...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38555857/molecular-characterization-as-new-driver-in-prognostic-signatures-and-therapeutic-strategies-for-endometrial-cancer
#28
REVIEW
Elisa D'Agostino, Luciana Mastrodomenico, Ornella Ponzoni, Cinzia Baldessari, Claudia Piombino, Stefania Pipitone, Maria Giuseppa Vitale, Roberto Sabbatini, Massimo Dominici, Angela Toss
Endometrial cancer (EC) incidence and mortality rates have been increasing, particularly among young females. Although more than 90% of ECs are sporadic, 5-10% are hereditary, a majority of which occurs within Hereditary Non-Polyposis Colorectal Cancer syndrome (HNPCC) or Lynch syndrome. The traditional histopathological classification differentiates EC between two main groups: type I (or endometrioid) and type II (including all other histopathological subtypes). However, this classification lacks reproducibility and does not account for the emerging molecular heterogeneity...
March 27, 2024: Cancer Treatment Reviews
https://read.qxmd.com/read/38551987/circulating-microrna-signature-predicts-cancer-incidence-in-lynch-syndrome-a-pilot-study
#29
JOURNAL ARTICLE
Tero Sievänen, Tiina Jokela, Matti Hyvärinen, Tia-Marje Korhonen, Kirsi Pylvänäinen, Jukka-Pekka Mecklin, Juha Karvanen, Elina Sillanpää, Toni T Seppälä, Eija K Laakkonen
Lynch syndrome (LS) is the most common autosomal dominant cancer syndrome and is characterized by high genetic cancer risk modified by lifestyle factors. This study explored whether a circulating microRNA (c-miR) signature predicts LS cancer incidence within a 4-year prospective surveillance period. To gain insight how lifestyle behavior could affect LS cancer risk, we investigated whether the cancer-predicting c-miR signature correlates with known risk-reducing factors such as physical activity, body mass index (BMI), dietary fiber or non-steroidal anti-inflammatory drug usage...
March 29, 2024: Cancer Prevention Research
https://read.qxmd.com/read/38551561/prevalence-morbidity-and-mortality-of-men-with-sex-chromosome-aneuploidy-in-the-million-veteran-program-cohort
#30
JOURNAL ARTICLE
Shanlee M Davis, Craig Teerlink, Julie A Lynch, Bryan R Gorman, Meghana Pagadala, Aoxing Liu, Matthew S Panizzon, Victoria C Merritt, Giulio Genovese, Judith L Ross, Richard L Hauger
IMPORTANCE: The reported phenotypes of men with 47,XXY and 47,XYY syndromes include tall stature, multisystem comorbidities, and poor health-related quality of life (HRQOL). However, knowledge about these sex chromosome aneuploidy (SCA) conditions has been derived from studies in the less than 15% of patients who are clinically diagnosed and also lack diversity in age and genetic ancestry. OBJECTIVES: To determine the prevalence of clinically diagnosed and undiagnosed X or Y chromosome aneuploidy among men enrolled in the Million Veteran Program (MVP); to describe military service metrics of men with SCAs; and to compare morbidity and mortality outcomes between men with SCA with and without a clinical diagnosis vs matched controls...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38548925/challenges-and-opportunities-for-lynch-syndrome-cascade-testing-in-the-united-states
#31
REVIEW
Lauren E Passero, Megan C Roberts
Lynch syndrome is an underdiagnosed genetic condition that increases lifetime colorectal, endometrial, and other cancer risk. Cascade testing in relatives is recommended to increase diagnoses and enable access to cancer prevention services, yet uptake is limited due to documented multi-level barriers. Individual barriers such as feelings of fear, guilt, and anxiety and limited knowledge about Lynch syndrome as well as interpersonal barriers including complex family dynamics and language barriers limit family communication about Lynch syndrome and prevent uptake of genetic screening for relatives...
March 28, 2024: Familial Cancer
https://read.qxmd.com/read/38546827/imaging-approaches-for-the-diagnosis-of-genetic-diseases-affecting-the-female-reproductive-organs-and-beyond
#32
REVIEW
Miki Yoshida, Tsukasa Saida, Toshitaka Ishiguro, Masafumi Sakai, Saki Shibuki, Shun Kagaya, Yoshiki Fujihara, Kensaku Mori, Toyomi Satoh, Takahito Nakajima
This review aims to provide an overview of neoplastic lesions associated with genetic diseases affecting the female reproductive organs. It seeks to enhance our understanding of the radiological aspects in diagnosing genetic diseases including hereditary breast and ovarian cancer syndromes, Lynch syndrome, Peutz-Jeghers syndrome, nevoid basal cell carcinoma syndrome, and Swyer syndrome, and explores the patterns and mechanisms of inheritance that require elucidation. Additionally, we discuss the imaging characteristics of lesions occurring in other regions due to the same genetic diseases...
March 28, 2024: Abdominal Radiology
https://read.qxmd.com/read/38546397/piga-mutations-and-glycosylphosphatidylinositol-anchor-dysregulation-in-polyposis-associated-duodenal-tumorigenesis
#33
JOURNAL ARTICLE
Elena Meuser, Kyle Chang, Angharad Walters, Joanna J Hurley, Hannah D West, Iain Perry, Matthew Mort, Laura Reyes-Uribe, Rebekah Truscott, Nicholas Jones, Rachel Lawrence, Gareth Jenkins, Peter Giles, Sunil Dolwani, Bilal Al-Sarireh, Neil Hawkes, Emma Short, Geraint T Williams, Melissa W Taggart, Kim Luetchford, Patrick M Lynch, Diantha Terlouw, Maartje Nielsen, Sarah-Jane Walton, Andrew Latchford, Susan K Clark, Julian R Sampson, Eduardo Vilar, Laura E Thomas
The pathogenesis of duodenal tumours in the inherited tumour syndromes Familial Adenomatous Polyposis (FAP) and MUTYH-associated Polyposis (MAP) is poorly understood. This study aimed to identify genes that are significantly mutated in these tumours and to explore the effects of these mutations. Whole exome and whole transcriptome sequencing identified recurrent somatic coding variants of PIGA in 19/70 (27%) FAP and MAP duodenal adenomas, and further confirmed the established driver roles for APC and KRAS. PIGA catalyses the first step in glycosylphosphatidylinositol (GPI) anchor biosynthesis...
March 28, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38534264/sebaceomas-in-a-muir-torre-like-phenotype-in-a-patient-with-mutyh-associated-polyposis
#34
Julia Guarrera, James C Prezzano, Kathleen A Mannava
This case report describes a case of a patient with MUTYH-associated polyposis (MAP), who presented with multiple sebaceomas in a Muir-Torre-like phenotype. MAP is caused by mutations in MUTYH, a base excision repair gene responsible for detecting and repairing the 8-oxo-G:A transversion caused by reactive oxygen species. MAP is associated with an increased risk of developing adenomatous polyps and colorectal cancer. Muir-Torre syndrome is a clinical phenotype of Lynch syndrome, which presents with multiple cutaneous sebaceous neoplasms...
March 4, 2024: Dermatopathology (Basel, Switzerland)
https://read.qxmd.com/read/38532453/current-prospects-of-hereditary-adrenal-tumors-towards-better-clinical-management
#35
REVIEW
Akihiro Ohmoto, Naomi Hayashi, Shunji Takahashi, Arisa Ueki
Adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL) are two rare types of adrenal gland malignancies. Regarding hereditary tumors, some patients with ACC are associated with with Li-Fraumeni syndrome (LFS), and those with PPGL with multiple endocrine neoplasia type 2. Recent studies have expanded this spectrum to include other types of hereditary tumors, such as Lynch syndrome or familial adenomatous polyposis. Individuals harboring germline TP53 pathogenic variants that cause LFS have heterogeneous phenotypes depending on the respective variant type...
March 26, 2024: Hereditary Cancer in Clinical Practice
https://read.qxmd.com/read/38531626/extent-of-investigation-and-management-of-cases-of-unexplained-mismatch-repair-deficiency-u-dmmr-a-uk-cancer-genetics-group-consensus
#36
JOURNAL ARTICLE
Terri Patricia McVeigh, Kevin J Monahan, Joseph Christopher, Nick West, Malcolm Scott, Jennie Murray, Helen Hanson
BACKGROUND: Mismatch repair deficiency (dMMR) is a characteristic feature of cancers linked to Lynch syndrome. However, in most cases, it results from sporadic somatic events rather than hereditary factors. The term 'Lynch-like syndrome' (LLS) has been used to guide colorectal cancer surveillance for relatives of individuals with a dMMR tumour when somatic and germline genomic testing is uninformative. As the assessment of mismatch repair through immunohistochemistry and/or microsatellite instability is increasingly applied across various tumour types for treatment planning, dMMR is increasingly detected in tumours where suspicion of hereditary aetiology is low...
March 26, 2024: Journal of Medical Genetics
https://read.qxmd.com/read/38521284/emerge-of-colorectal-cancer-in-lynch-syndrome-despite-colonoscopy-surveillance-a-challenge-of-hide-and-seek
#37
REVIEW
Noah C Helderman, Monique E van Leerdam, Matthias Kloor, Aysel Ahadova, Maartje Nielsen
Even with colonoscopy surveillance, Lynch syndromes (LS) carriers still develop colorectal cancer (CRC). The cumulative incidence of CRCs under colonoscopy surveillance varies depending on the affected mismatch repair (MMR) gene. However, the precise mechanisms driving these epidemiological patterns remain incompletely understood. In recent years, several potential mechanisms explaining the occurrence of CRCs during colonoscopy surveillance have been proposed in individuals with and without LS. These encompass biological factors like concealed/accelerated carcinogenesis through a bypassed adenoma stage and accelerated progression from adenomas...
March 21, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38508587/molecular-and-pathologic-data-to-guide-selection-of-patients-with-endometrioid-endometrial-cancer-for-ovarian-preservation
#38
JOURNAL ARTICLE
Beryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, Lora H Ellenson, Qin C Zhou, Alexia Iasonos, Mario M Leitao, Nadeem R Abu-Rustum, Britta Weigelt, Jennifer J Mueller
OBJECTIVES: To investigate the association of molecular and pathologic factors with concurrent or recurrent ovarian disease to guide ovarian preservation in endometrioid endometrial cancer. METHODS: Patients with endometrial cancer ≤50 years of age at diagnosis were grouped by elective oophorectomy versus ovarian preservation at staging (January 2010 to June 2021). Tumors were stratified by molecular sub-type and CTNNB1 mutational status with next generation sequencing and immunohistochemistry...
March 19, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38508486/ex-vivo-lung-perfusion-in-donation-after-circulatory-death-a-post-hoc-analysis-of-the-novel-trial
#39
JOURNAL ARTICLE
Doug A Gouchoe, Pablo G Sanchez, Jonathan D'Cunha, Christian A Bermudez, Mani A Daneshmand, Robert D Davis, Matthew G Hartwig, Thomas C Wozniak, Zachary N Kon, Bartley P Griffith, William R Lynch, Tiago N Machuca, Michael J Weyant, Michael E Jessen, Michael S Mulligan, Frank D'Ovidio, Phillip C Camp, Edward Cantu, Bryan A Whitson
OBJECTIVE: Donation after circulatory death (DCD) donors offer the ability to expand the lung donor pool and ex vivo lung perfusion (EVLP) further contributes to this ability by allowing for additional evaluation and resuscitation of these extended criteria donors. We sought to determine the outcomes of recipients receiving organs from DCD EVLP donors in a multi-center setting. METHODS: This was an unplanned post-hoc analysis of a multicenter, prospective, non-randomized trial that took place in 2011-2017 with 3-years of follow up...
March 18, 2024: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38502210/risk-of-metachronous-colorectal-cancer-after-surgical-resection-of-index-rectal-cancer-in-lynch-syndrome-a-multicenter-retrospective-study-in-japan
#40
JOURNAL ARTICLE
Kenichi Chikatani, Hideyuki Ishida, Yoshiko Mori, Takeshi Nakajima, Arisa Ueki, Kiwamu Akagi, Akinari Takao, Masayoshi Yamada, Fumitaka Taniguchi, Koji Komori, Kazuhito Sasaki, Tomoya Sudo, Yasuyuki Miyakura, Akiko Chino, Tatsuro Yamaguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka
PURPOSE: This study evaluated the risk of metachronous colorectal cancer (CRC) after resection of index (first) rectal cancer in patients with Lynch syndrome (LS). METHODS: Clinicopathological data of patients with genetically proven LS were retrospectively analyzed in this multicenter Japanese study. The cumulative incidence of metachronous CRC and the overall survival were compared between patients with index rectal cancer (rectal group) and those with index colon cancer (colon group)...
March 19, 2024: Surgery Today
keyword
keyword
6598
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.